Tags : Improve


P&G Signs a License Agreement with Rhinostics to Launch its

Shots: Rhinostics plans to register the P&G polypropylene nasal swab as a Class I Exempt medical device and will pursue Emergency Use Authorization for home collection with rPT-PCR testing for detection of SARS-CoV-2 infection Rhinostics Standard Nasal Swab is a polypropylene collection device developed in partnership with P&G for COVID-19 testing which provides sample concentration […]Read More


Eli Lilly Collaborates with Dexcom for Diabetes Management

Shots: The companies will partner to promote Lyumjev (insulin lispro-aabc injection, 100 & 200 units/mL) with Dexcom G6 CGM to aid HCPs in the US for the management of diabetes, including giving visibility to the benefits of a new mealtime insulin HCPs treating T1D & T2D will be able to assess their patient’s glucose levels […]Read More


Roche and Cipla Expand Their 2018 Agreement to Improve Access

Shots: Cipla expands partnership with Roche to improve access to key oncology medicines which include Herclon (trastuzumab), Avastin (bevacizumab) and Ristova (rituximab) in India. Cipla will be responsible for the marketing and distribution of Roche’s key products In Feb’2018, the two companies collaborated for the promotion and distribution of Actemra (tocilizumab) and other products  The […]Read More


Akili’s EndeavorRx Receives the US FDA’s Approval as the First

Shots: The FDA’s De novo clearance is based on five clinical studies in 600+ children diagnosed with ADHD, which demonstrated an improved measure of attention. After 4wks., one-third of children had no longer measurable attention deficit on at least one measure of objective attention Change in child’s day-to-day impairments following @1mos. treatment with EndeavorRx which […]Read More